µ±Ç°Î»ÖãºÖÐÔ­ÐóÄÁÍø -> ¶¯Îï·±Ö³ -> ¶¯Îï·±Ö³ -> AFLP·Ö×Ó±ê¼Ç¼¼Êõ¼°ÔÚÈ®ÓýÖÖÑо¿ÖеÄÓ¦ÓÃǰ¾°
 

AFLP·Ö×Ó±ê¼Ç¼¼Êõ¼°ÔÚÈ®ÓýÖÖÑо¿ÖеÄÓ¦ÓÃǰ¾°

ÈÕÆÚ£º2006-5-9 11:34:00  À´Ô´£º²»Ïê Ö÷Ì⣺AFLP·Ö×Ó±ê¼Ç¼¼Êõ¼°ÔÚÈ®ÓýÖÖÑо¿ÖеÄÓ¦ÓÃǰ¾°


Âí³¤Êé1£¬ÂíΡ2£¬ÑîǰÓÂ3

£¨1£¬3£®¹«°²²¿Äϲý¾¯È®»ùµØ£¬2£®ÄϾ©Å©Òµ´óѧ¶¯Îï·±ÓýÑо¿Ëù£©

ÕªÒª£ºAFLP£¨À©ÔöƬ¶Î³¤¶È¶à̬ÐÔ£©¼¼ÊõÒòÆäÎÞÐèÁ˽â´ý²âDNAÐòÁС¢¸ßЧÇÒ·Ö±æÂʸߡ¢Öظ´ÐԺõÈÌØµãÒѱ»Ó¦ÓÃÓÚ¹¹½¨ÒÅ´«Í¼Æ×¡¢ÒÅ´«¶à̬ÐÔ·ÖÎö¡¢Æ·ÖÖ¼ø¶¨¡¢¼²²¡Õï¶ÏµÈµÄÑо¿ÖС£±¾ÎĽéÉÜÁËAFLP¼¼ÊõµÄÔ­Àí¡¢·½·¨¡¢Ìص㡢¼¼Êõ¹Ø¼ü£¬²ûÊöÁËAFLPÔÚÈ®ÓýÖÖÖеÄÓ¦ÓÃǰ¾°¡£

¹Ø¼ü´Ë£ºAFLP£»È®£»Ó¦ÓÃǰ¾°

AFLP and its prospect of application to canine breeding

Abstract: AFLP£¨amplified fragment length polymorphism£©can generate fingerprints of any DNA without much prior sequence knowledge. Data produced by AFLP are highly efficient, highly differentiate and reproducible. So it has been used in the construction of linkage genetic maps, analysis of genetic polymorphism, identification of breed and disease diagnosis. The principle, methodology, trait, key of technique and application prospect in canine breeding were induced in this paper.

Key words: AFLP ; canine ; prospect of application

AFLP£¨amplified fragment length polymorphism.À©ÔöƬ¶Î³¤¶È¶à̬ÐÔ£©ÊÇÔÚRAPDºÍRFLP±ê¼Çϵͳ»ù´¡ÉÏ·¢Õ¹ÆðÀ´µÄ·Ö×Ó±ê¼Ç[1]£¬ÊÇÓÉZabeau MarcºÍVos PieterÓÚ1992Äê´´Á¢[2]£¬ÓÚ1993Äê»ñÅ·ÖÞרÀû¾ÖרÀû£¨×¨ÀûºÅEP0534858AI£©¡£¸Ã¼¼ÊõÊ×ÏÈÔËÓÃÓÚÖ²Îï·Ö×ÓÉúÎïѧµÄÑо¿ÖÐ[3]£¬µ«ÒòÔÚ²Ù×÷¹ý³ÌÖÐÆä²»ÐèÒªÁ˽â´ý²âDNAÐòÁС¢¿ìËÙ¡¢¸ßЧ,ÇÒ·Ö±æÂʸߡ¢Öظ´ÐԺá¢Ò×ÓÚ±ê×¼»¯µÈÌØµãºÜ¿ì±»Íƹ㵽ÉúÎïѧµÄ¸÷¸öÁìÓò£¬ÈçÒÅ´«Í¼Æ×µÄ¹¹½¨¡¢ÒÅ´«¶àÑùÐÔºÍϵͳ·¢Éú¡¢»ùÒò»ò»ùÒò×éÇøÓòÌØÒìÐÔ±ê¼ÇµÄɸѡºÍ¶¨Î»¡¢Ï¸¾ú¼ø¶¨ÒÔ¼°¼²²¡Õï¶ÏºÍÖ×ÁöµÈ·½ÃæµÄÑо¿[4-8]¡£

1£®AFLPµÄÔ­ÀíºÍ·½·¨£º

    AFLPÊÇͨ¹ýDNA¶à¾ÛøÁ´Ê½·´Ó¦(PCR)À©Ôö»ùÒò×éDNAµÄÄ£°å¶ø²úÉú¡£DNA¶à¾ÛøÀûÓÃÒ»¶ÎÒýÎïÒÔ½âÁ´ºóµÄµ¥Á´DNAΪģ°å,ÑØ×Å5¡äµ½3¡ä·½Ïò°ÑºËÜÕËáÁ¬Ðø¼ÓÔÚÑÓÉìµÄ3¡äôÇ»ùÉϸ´ÖÆDNA¡£ÓÉÓÚ²»Í¬ÎïÖÖ»ò²»Í¬Æ·ÖֵĻùÒò×éDNA´óС²»Í¬,¶ÔÒýÎïËùÓÕµ¼¸´ÖƵÄÌØ¶¨DNAƬ¶Î²ÉÓÃPCR¼¼Êõ½øÐÐÀ©Ôö,È»ºóÓõçÓ¾·½·¨½«À©ÔöµÄDNAƬ¶Î·ÖÀë,¼´¿ÉʹijһƷÖÖ³öÏÖÌØ¶¨µÄDNA´øÆ×(¼´À©ÔöƬ¶Î³¤¶È¶à̬ÐÔ),¶øÔÚÁíһƷÖÖÖпÉÄÜÎÞ´ËÆ×´ø²úÉú,Òò´ËÕâÖÖͨ¹ýÒýÎïÓÕµ¼¼°DNAÀ©ÔöºóµÃµ½µÄDNA¶à̬ÐÔ¿É×÷ΪһÖÖ·Ö×Ó±ê¼Ç, ¼´AFLP±ê¼Ç¡£

AFLP¼¼Êõ°üÀ¨Èý¸ö²½Öè[9]£º¢ÙÓÃÃÜÇÐøºÍÏ¡ÇÐøÁ½¸öÇÐ¸îÆµÂʲ»Í¬µÄÏÞÖÆÐÔÄÚÇÐøÏû»¯»ùÒò×éDNA£¬È»ºóÔÚÇпڴ¦Á¬½Óº¬ÏàͬÄÚÇÐøλµãµÄ¡°½ÓÍ·¡±(Adapter);¢ÚÑ¡ÔñÐÔÀ©ÔöøÇÐÆ¬¶Î,¸ù¾Ý½ÓÍ·Éè¼ÆÒýÎï,AFLPµÄÒýÎï°üÀ¨ÓëÈ˹¤½ÓÍ·»¥²¹µÄºËÐÄÐòÁÐ(CORE)¡¢ÏÞÖÆÐÔÄÚÇÐøʶ±ðÐòÁÐ(ENZ)ºÍ3¡ä¶ËÑ¡ÔñÐÔ¼î»ùÈý²¿·Ö¡£À©Ôöʱһ°ã²ÉÓÃÁ½²½·¨,Ê×ÏÈÓõ¥Ñ¡Ôñ¼î»ùµÄÒýÎï½øÐÐÔ¤À©Ôö·´Ó¦,Ô¤À©Ôö²úÎïÏ¡ÊͺóÓÃ2¡ª3Ñ¡Ôñ¼î»ùÑ¡ÔñÐÔÀ©Ôö¡£²ÉÓÃÁ½²½·¨µÄÓŵãÊÇ¿ÉÒÔÌá¸ßÀ©ÔöÌØÒìÐÔ,½µµÍAFLPͼÆ×µÄÃÖÉ¢±³¾°£¬¿ÉʹÀ©Ôö´øÊý¼õÉÙ£¬´Ó¶øÊ¹²úÉúµÄÖ¸ÎÆÍ¼Æ×¸üÇåÎúºÍ¾ßÓиüºÃµÄÖØ¸´ÐÔ£¬ÔÙÕßÊÇÌṩ´óÁ¿µÄÄ£°åDNA¡£,;¢ÛÀ©ÔöƬ¶Îͨ¹ý±äÐÔ¾Û±ûÏ©õ£°·Äý½ºµçÓ¾·ÖÀë¼ì²â¡£¼ì²â»ùÒò×éÒòÏÞÖÆÐÔøÇÐλµã¡¢Ñ¡ÔñÐÔ¼î»ù½áºÏλµãËù·¢ÉúµÄ¼î»ùÍ»±ä¡¢²åÈ롢ȱʧ»òÌæ»»¶ø²úÉúµÄÀ©ÔöƬ¶ÎÓÐÎÞ¶à̬,»òÒòÁ½Ñ¡ÔñÐÔÒýÎï½áºÏλµãÇøÓò¼ä´æÔÚ¼î»ù²åÈë»òȱʧ¶øµ¼ÖµÄÀ©ÔöƬ¶Î³¤¶ÈµÄ¶à̬¡£ÔÚ²»ÐèÒªÊÂÏÈÖªµÀDNAÐòÁÐÐÅÏ¢µÄǰÌáÏÂ,¾Í¿É¶ÔøÇÐÆ¬¶Î½øÐо­µäµÄPCRÀ©Ôö¡£

2£®AFLPµÄÌØµã

AFLP×ÛºÏÁËRFLPºÍRAPD¼¼ÊõµÄÓŵ㣬¿É¼ì²âµ½·Ö²¼ÓÚÈ«»ùÒò×éÉϵÄDNAƬ¶Î¡£AFLP¼¼ÊõËäµ®ÉúµÄʱ¼äºÜ¶Ì,µ«ÓÉÓÚÆä¶Àµ½µÄ¼ì²âDNA¶à̬ÐԵķ½Ê½,ÒѳÉΪ»ùÒò×éÑо¿µÄ·Ç³£ÓÐÓõŤ¾ß,±¸ÊÜÒÅ´«Ñ§¼ÒºÍ·Ö×Óѧ¼ÒµÄÇàíù,Ó¦Ó÷¶Î§Ô½À´Ô½¹ã·º,Æä¶ÀÌØµÄÓŵãÓУº¢ÙAFLPͬRAPDÒ»Ñù,²»ÐèÒªÔ¤ÏÈÖªµÀËùÒªÀ©ÔöDNAµÄÐòÁÐ,Êʺ϶ÔÒÅ´«±³¾°²»¶àºÍ»ùÒò×éÑо¿²»³ä·ÖµÄÖÖÀà½øÐзÖÎö¡£²»ÂÛÀ´Ô´ºÍ¸´ÔÓÐÔÈçºÎ,ÈκÎDNA¶¼¿ÉµÃµ½AFLPµÄÖ¸ÎÆÍ¼Æ×£»¢Ú¾ßÓÐÒ»¶¨µÄÁé»îÐÔ,¿Éͨ¹ýÌØÒìÐÔPCRÒýÎïµÄÉè¼ÆºÍÄÚÇÐø×éºÏµÄÑ¡ÔñÒÔ¼°Ñ¡ÔñÐÔÀ©Ôö¼î»ùµÄÊýĿȥ¿ØÖÆAFLPͼÆ×ÖÐÌõ´øµÄÊýÁ¿;¢Û ¶à̬ÐÔÇ¿£¬·Ö±æÂʸߡ£AFLP¼¼ÊõÊÇÕë¶ÔÕû¸ö»ùÒò×éµÄ,Òò´Ë¿Éͬʱ¶ÔËæ»ú·Ö²¼ÔÚȾɫÌåÉϵÄÐí¶à²»Í¬µÄDNAÇøÓò¶àλµã½øÐзÖÎö£¬¶øÇÒAFLP¿É»ñµÃ¸ßÃܶȱê¼ÇÓëÆäËüÒÅ´«±ê¼ÇÏà±È,AFLP¾ßÓÐ×î¸ßµÄÐÅÏ¢º¬Á¿(ÐíÕ¼ÓѵÈ,2000)¡£ÕâЩAFLP±ê¼ÇÖÐÖÁÉÙÓв¿·Ö±ê¼ÇλÓÚ±äÒìµÄÇøÓò,Òò´Ë¿ÉÒÔչʾÖÖȺÄÚ΢СµÄÒÅ´«±äÒì,²¢¿ÉÒÔÓòâÐòÄý½ºÀ´Çø·ÖAFLPÀ©Ôö´ø¼äµÄµ¥¸öºËÜÕËáµÄ²îÒ죻¢ÜÖØ¸´ÐԺ㬠AFLPÐè¸ßÖÊÁ¿µÄDNAºÍ¹ýÁ¿µÄø¿ÉÒÔ¿Ë·þÒòDNAµÄøÇв»ÍêÈ«¶ø²úÉúµÄÊ§Õæ,ÌØÒìÐÔµÄPCRÒýÎï¡¢Á½²½·¨µÄÀ©ÔöºÍ½Ï¸ßµÄÍË»ðζȣ¨56¡æ£©½«Îó²î¼õÉÙµ½×îµÍÏÞ¶È¡£JonesµÈ[10]ÓÃAFLP̽ÕëÔÚÅ·ÖÞ8¸ö²»Í¬µÄʵÑéÊÒÖ®¼ä½øÐмì²â,·¢ÏÖÆä´íÎóÂÊСÓÚ0 6%¡£

µ«AFLPÒ²ÓÐÆä×ÔÉíµÄȱµã£º¢ÙAFLPÊÇÒ»ÖÖרÀû¼¼Êõ,ÊÜרÀûȨ±£»¤£¬ÊµÑé³É±¾ºÍÔì¼Û±È½Ï¸ß,ÌØ±ðÊÇ4¼î»ùÏÞÖÆÐÔÄÚÇÐøµÄ¼Û¸ñÊ®·Ö°º¹ó; ¢ÚAFLP¶Ô»ùÒò×éDNAµÄÖÊÁ¿ÓнϸߵÄÒªÇó,²»Äܺ¬ÄÚÇÐøµÄÒÖÖÆ¼Á£¨µ°°×ÖÊ¡¢²ÐÁô·Ó¡¢¶àÌǵȣ©,ÒòΪAFLPÒªÇó»ùÒò×éDNAÍêȫøÇÐ,Èç¹ûøÇкÍÁ¬½Ó²»ÍêÈ«¿ÉÄÜ»áÀ©Ôö³ö±»ÈÏΪÊǶà̬ÐԵĴø,µ¼Ö´íÎóµÄ·ÖÎö½á¹û¡£¢ÛÓÉÓÚĿǰ¶Ô»ùÒò×é¡¢ÌØ±ðÊǸ´ÔÓ»ùÒò×éµÄÈÏʶ³Ì¶È»¹Ê®·ÖÓÐÏÞ£¬ÕâʹÄÚÇÐø/ÒýÎïµÄÑ¡ÔñºÍÉè¼ÆÉϳöÏÖÁËÒ»¶¨µÄäĿÐÔ£»¢ÜAFLP²úÉúµÄ±ê¼Ç¶àÊýÊÇÏÔÐÔµÄ, Æä¶à̬µÄͳ¼ÆÊÇ»ùÓÚøÇÐÆ¬¶ÎµÄÓÐÎÞ£¬Òò´Ë²»ÄÜÇø·ÖijһλµãÊÇÔÓºÏÌ廹ÊÇ´¿ºÏÌå¡£Óë¹²ÏÔÐÔ±ê¼ÇÏà±È,²»ÄܸüºÃµØ¹ÀËãÖÖȺÒÅ´«µÄ±äÒì¡£ÁíÍâAFLPΪÄäÃû±ê¼Ç£¬²»ÖªÆäȾɫÌåµÄ·Ö²¼Çé¿ö[11]¡£

3£®AFLPµÄ¼¼Êõ¹Ø¼ü

3£®1 ÏÞÖÆÐÔÄÚÇÐøµÄÑ¡Ôñ

    ÏÞÖÆÐÔÄÚÇÐøµÄÑ¡Ôñ¶ÔAFLP·ÖÎöµÄ׼ȷ¶È¾ßÓйؼüÐÔ×÷ÓÃ,AFLP·ÖÎö¿ÉÒÔ²ÉÓõÄøÓÐÐí¶àÖÖ,°üÀ¨EcoR¢ñ¡¢Hind¢ó¡¢Apa¢ñ¡¢Tag¢ñ¡¢Msp¢ñ¡¢Hpa¢ò¡¢Mse¢ñ¡¢Pst¢ñµÈ¡£EcoR¢ñ¿É¿¿¡¢¸ßЧ¶ø¼ÛÁ®,ÊÇÁù¼î»ùÄÚÇÐø(Ï¡ÇÐø)µÄÊ×ѡøÀࣻËļî»ùÄÚÇÐø£¨ÃÜÇÐø£©,ÔÚ·ÖÎö¸»º¬¡ªATÐòÁеÄÖ²ÎïºÍ΢ÉúÎï»ùÒò×éʱ´ó¶àÑ¡ÓÃMseI,ÒòΪMseIµÄʶ±ðÐòÁÐΪTTAA¡£²»¹ý,¶Ô¶¯Îï»ùÒò×é½øÐÐAFLP·ÖÎöʱ³£ÓÃTaqIÈ¡´úMseI,ÒòΪÔÚ¶¯Îï»ùÒò×éÖÐ,GCË«¼î»ùÐòÁÐÊô¸ß¶È¶àÒìÇø,¶à̬ÐԷḻ,¶øTaqIµÄʶ±ðλµã(TC-GA)º¬GCË«¼î»ùÐòÁÐ,¿É»ñµÃ¸ü¶àµÄAFLP¶à̬±ê¼Ç,µ«ÊÇÒ²Óб¨µÀHind¢óÊʺÏG£«Cº¬Á¿Îª40¡«50%µÄ»ùÒò×é[12]¡£

3£®2 ½ÓÍ·£¨adapter£©ºÍÒýÎï

½ÓÍ·ÊÇÈ˹¤ºÏ³ÉµÄÒ»¶Î¶ÌºËÜÕËáË«Á´£¬ÓɺËÐÄÐòÁУ¨core sequence£©ºÍø»¯ÐòÁУ¨enzyme specific sequence£©Á½²¿·Ö×é³É¡£½ÓÍ·µÄÉè¼Æ³ýÁËÓëÏàÓ¦µÄøÏàÆ¥ÅäÍ⣬»¹Ó¦×ñÑ­ÒÔÏÂÔ­Ôò£º¢Ù¾ßÓкÏÊʵÄGCº¬Á¿£¬ÏÞÖÆÐÔÆ¬¶ÎÓë¶ÔÓ¦½ÓÍ·Á¬½ÓºóÒª±£Ö¤Ô­ÏÞÖÆÐÔÄÚÇÐøλµã²»µÃ»Ö¸´£»¢Ú½ÓÍ·²»±»Á×Ëữ£¬ÕâÑù¿ÉÒÔ±ÜÃâ½ÓÍ·Óë½ÓÍ·¼äµÄÁ¬½Ó¡£

ÒýÎïµÄÉè¼ÆÊÇPCRÀ©ÔöµÄ¹Ø¼ü,¶øÒýÎïÉè¼ÆÖ÷ÒªÔÚÑ¡Ôñ¼î»ùÊýÄ¿¼°×éºÏÉÏ¡£AFLPµÄÒýÎﳤ¶ÈÒ»°ãΪ16¡«20¸ö¼î»ù£¬Ñ¡ÔñÐÔÑÓÉ첿·ÖÓÐ1¡«3¸öºËÜÕËá×é³É£¬ÔÚÕâ¸ö·¶Î§ÄÚÿÔö¼ÓÒ»¸öÑ¡ÔñÐÔºËÜÕËá¿ÉÒÔʹÀ©ÔöÌõ´ø¼õÉÙµ½Ô­ÓÐÌõ´øµÄ1/4[13]¡£¾ßÌåµÄÑ¡Ôñ¼î»ùÊýĿȡ¾öÓÚËùÑо¿ÎïÖÖ»ùÒò×éµÄ´óС,΢ÉúÎï»ùÒò×é½ÏС,¶à²ÉÓÃÒ»¸öÑ¡ÔñÐÔºËÜÕË᣻105¡«108bp»ùÒò×é¿ÉÒÔÓÃ2¸öÑ¡ÔñÐÔºËÜÕË᣻´óÓÚ108bpµÄ»ùÒò×é¿ÉÒÔÓÃ3¸öÑ¡ÔñÐÔºËÜÕËá¡£¶ÔÓÚÑ¡ÔñÐÔºËÜÕËáµÄ×éºÏ£¬»ùÒò×éÖÐG£«Cº¬Á¿»ùÒò×éÆäÑ¡ÔñÐÔÒýÎï3¡¯Ñ¡£Á»ò£Ô,·´Ö®,¿ÉÑ¡£Ã¡£AFLPÒýÎïµÄÁíÒ»¸öÖØÒªÌØÕ÷ÊÇËùÓÐÒýÎï5¡¯¶ËÊÇG¼î»ù,Ëü¿ÉÒÔÓÐЧ·Àֹ˫Á´ÐγÉ[14]¡£

4£®AFLPÔÚ¾¯È®Ñо¿ÖеÄÓ¦ÓÃǰ¾°

´Ó½ø»¯½Ç¶È¿´£¬ÈË¡¢ÊóºÍ¹·ÔøÓµÓй²Í¬×æÏÈ£¬ÈËÀàÓë¹·»ùÒò×éÖ®¼äÔ¼ÓÐ6.5ÒÚ¸ö¼î»ù¶Ô²¿·ÖÏàͬ£¬ÔÚÒÑʶ±ð³öµÄ2.4Íò¶à¸öÈËÀà»ùÒòÖУ¬ÖÁÉÙÓÐ18473¸öÓë¹·µÄ»ùÒòÏàͬ¡£¾Ý¹À¼Æ£¬¹·ÉíÉÏÓÐ360¶àÖÖÒÅ´«¼²²¡ÓëÈËÀ༲²¡ÏàËÆ¡£Òò´Ë¶ÔÈ®»ùÒò×éµÄ²â¶¨Óë·ÖÎö²»½ö¶ÔÈ®µÄÓýÖÖºÍÒÅ´«¼²²¡µÄÑо¿Óë·ÀÖÎÓдٽø×÷Ó㬶øÇÒҲΪÈËÀà×ÔÉíµÄÒÅ´«¼²²¡ÌṩÁË×îÖ±½ÓµÄÄ£ÐÍ¡£ÃÀ¹ú¹ú¼ÒÈËÀà»ùÒò×éÑо¿Ëù£¨NHGRI£©2002Äê9ÔÂÐû²¼£¬È®¡¢Å£ºÍÒ»ÖÖÏËë³æÒѱ»ÁÐÈë»ùÒò×éÐèÒª²âÐòµÄ¸ßÓÅÏȼ¶ÉúÎï¹Ù·½×¢²áÃûµ¥¡£AFLP×÷ΪһÃÅÐÂÐË·Ö×Ó±ê¼Ç¼¼Êõ£¬Ä¿Ç°Ëäδ¼ûÆäÓ¦ÓÃÓÚÈ®»ùÒò×éÑо¿µÄ±¨µÀ£¬µ«AFLPÔÚ΢ÉúÎï¡¢Ö²ÎïºÍÆäËû¶¯Îï·½ÃæµÄÓ¦ÓøøÓèÎÒÃÇÌáʾ¡£

4£®1 ¹¹½¨ÒÅ´«Í¼Æ×ºÍQTL¶¨Î»

AFLP¼¼Êõ¿ÉÒÔÓÃÓÚδ֪»ùÒò×éµÄ¶à̬±ê¼Ç£¬¶øÇÒ¿ÉÒÔËõÐ¡ÌØÕ÷»ùÒòÓëÁ¬Ëø±ê¼ÇÖ®¼äµÄ¾àÀ룬Ôö¼ÓȾɫÌåÄ©¶Ë±ê¼ÇºÍÌî³äRFLP¿Õ϶,²»¸ÉÈÅRFLP±ê¼Ç´Ø[15.16]¡£ºÉÀ¼Keygene¹«Ë¾Pot Jerina¹¹½¨ÁËÄâÄϽæ¸ßÃܶȵÄÒÅ´«Í¼Æ×£¬¹²700Óà¸öAFLPλµã¸²¸ÇÁËÄâÄϽæµÄÕû¸öȾɫÌå×é[17]¡£TanµÈ(2001)ÓÃAFLP¼¼Êõ¹¹½¨¼ÒÁ˲ϵÄÁ¬ËøÒÅ´«Í¼Æ×¡£ËûÃÇÓÃ35¸öÒýÎï×éºÏ»ñµÃÁË1248(60.7%)Ìõ¶à̬´ø·ÖÅäÔÚ30¸öÁ¬Ëø×é,³¤¶ÈÔÚ37.4¡«691.0cM£¬Á¬ËøÍ¼Æ××ܳ¤¶ÈΪ6512cM[18]¡£OtsenµÈ[16]ÔÚСÊóµÄÁ¬ËøÍ¼Æ×É϶¨Î»ÁË18¸öAFLP±ê¼Ç,²¢Ñо¿ÁËR¢ñ¼ÒϵÖеÄһЩѪѹÏÔÐÍÓëAFLP±ê¼Ç»ùÒòÐ͵ĹØÏµ,½«Á½¸öÏà¹ØµÄAFLP±ê¼Ç¶¨Î»ÔÚ20ºÅȾɫÌåÉÏ¡£ThomasÀûÓÃAFLPºÍ»ìºÏ·ÖÀë·ÖÎö£¨Bulked Segregation Analysis, BSA£©·¨»ñµÃÁË42000¸öAFLPλµã£¬²¢´ÓÖÐÕÒ³ö3¸öÓë·¬ÇÑcfg¿¹ÐÔ»ùÒò¹²·ÖÀëµÄAFLP±ê¼Ç[19]¡£Plastow G SµÈ£¨1998£©Í¨¹ý420¶ÔAFLPÒýÎï¼ì²âµ½13¸ö¿ÉÄÜÓëÖíëɫ»ùÒòÏà¹ØµÄ±ê¼Ç£¬ÆäÖÐCOLI±ê¼ÇÓëëɫ»ùÒò¢ñÏÔÖøÁ¬Ëø²»Æ½ºâ¡£

4£®2 ÒÅ´«¶àÑùÐÔ·ÖÎöºÍÆ·ÖÖ¼ø¶¨

AFLP·¨¹¹½¨µÄÖ¸ÎÆÍ¼Æ×¾ßÓжà̬ÐÔÇ¿¡¢Öظ´ÐԺá¢ÁéÃô¶È¸ßµÄÓŵã, AFLP»¹ÄÜÇø±ðºÜСµÄÒÅ´«²îÒì,Èç¼ø¶¨ÕûÌõȾɫÌåÉÏÏà²î½öÒ»µ¥Á´Ð¡Æ¬¶ÎµÄ´ó¶¹½üµÈλ»ùÒò[20],¡£Òò´Ë£¬AFLPÔÚ·ÖÎöÑÇÖÖˮƽµÄÒÅ´«±äÒì,ÓÈÆäÊDzⶨÖÖȺ½á¹¹ºÍ·Ö»¯¡¢Æ·ÖÖ¼ø¶¨·½ÃæµÃµ½×î¹ã·ºµÄÓ¦ÓᣲÜÉÙÏÈ¡¢ÑîÀû¹úµÈÓÃ29¸öAFLPÒýÎï×éºÏ·ÖÎöÁË3¸öɽÑòÆ·ÖÖ£¬¹²À©Ôö³ö3253¸ö±ê¼Ç£¬ÆäÖпɱä±ê¼Ç92¸ö¡£²¢¶ÔÈý¸öÆ·ÖÖµÄɽÑò×÷¾ÛÀà·ÖÎö¡£ÁºÖÇÓµÈÓ¦ÓÃ25¸öµ¥Ã¸ÇÐÒýÎïºÍ25¶Ô˫øÇÐÒýÎï¶Ô10¸öƷϵСÊó½øÐзÖÎö£¬¹²µÃµ½467¸ö¶à̬λµãºÜºÃµÄÇø·ÖÁËÒÅ´«±³¾°»òÍâ¹ÛÐÎ̬ºÜÏàËÆµÄƷϵ[21]¡£Èξü¡¢»ÆÂ·ÉúµÈÀûÓÃ12¶ÔAFLPÒýÎï×éºÏ¼ì²âÁË19¸öÖйúµØ·½ÖíÖÖ(Ⱥ)¡¢1¸öÅàÓýÖíÖÖºÍ4¸öÅ·ÃÀÒý½øÖíÖÖ»ìºÏ»ùÒò×éDNAµÄÒÅ´«±äÒì¡£½á¹û±íÃ÷, AFLP±ê¼ÇÓÐןܸߵĶà̬¼ì²âЧÂÊ(Ai),ƽ¾ùÿ¸öÒýÎï×éºÏ¼ì²âµ½17.3¸ö¶à̬±ê¼Ç,·Ç³£ÊʺÏÓÚÖíÖÖ(Ⱥ)ÒÅ´«¶àÑùÐÔ·ÖÎöºÍÆ·ÖÖ¼ø¶¨[11]¡£PAJmone,MarsamÓÃ16¸öAFLPÒýÎï×é·ÖÎöÁËÒâ´óÀûFresianţȺ47¸öÌåµÄÒÅ´«¶àÑùÐÔ¡£½á¹û±íÃ÷,AFLP±ê¼ÇµÄ¶àλµãÐÔ¡¢ºÜºÃµÄÎȶ¨ÐÔºÍÖØ¸´ÐÔʹµÃ¸Ã¼¼Êõ·Ç³£ÊÊÓÚ·ÖÎö¶¯Îï»ùÒò×é,¼ì²âÉúÎï¶àÑùÐÔ[22]¡£

4£®3 ¼²²¡Óë¼²²¡Õï¶Ï

ÏÖÓеÄȮƷÖÖ¶¼²»Í¬³Ì¶ÈµÄЯ´øÒÅ´«¼²²¡£¬ÀýÈçÔ¼ÓÐ10%µÄ°®¶ûÀ¼ÈüÌØÁÔ¹·Ð¯´øÒ»ÖÖ¿ÉÒýÆðÃâÒß¼²²¡µÄ»ùÒò£»µÂ¹úÄÁÑòÈ®ÓÐ132ÖÖÒ×»¼µÄÒÅ´«¼²²¡£¬Éæ¼°Á˹Ç÷À¡¢ÊÓ¾õ¡¢Æ¤·ô¡¢ÐÄѪ¹Ü¡¢Éñ¾­¡¢Ïû»¯ÏµÍ³²¢ÇÒÒÅ´«Ä£Ê½ºÍ·¢²¡ÄêÁä¶¼Óкܴó²îÒì[23]¡£ ͨ¹ýDNA¼ì²â±ÜÃâ¸Ã»ùÒòЯ´øÕß²ÎÓë½»Åä¿ÉÒԽϺõÄÔ¤·ÀÒÅ´«¼²²¡¡£Ä¿Ç°£¬AFLP²îÒìɸѡ¼¼Êõ±»¹ã·ºµØÓ¦ÓÃÔÚÖ×ÁöÑо¿·½Ãæ¡£FukudaµÈ[8]ÀûÓÃAFLP¼¼Êõ·ÖÎöÁËСÊó¿É×ªÒÆµÄ¹ÇÈâÁöcDNA,¿Ë¡µÃµ½4¸öÓë¹ÇÈâÁö¸ß×ªÒÆÐÔ×´Á¬ËøÏµÁеĻùÒò£»MajimaµÈ[24]½«Ò»ÖָĽøµÄAFLP¼¼ÊõÔËÓõ½´ÓTsc2»ùÒòÍ»±äÖ·¢ÉöÔàÖ×ÁöµÄСÊóÖзÖÀ벻ͬ±í´ïµÄ»ùÒò,Ò»ÖÖÃüÃûΪ¡°rising dbl quote , left (low) Niban¡±µÄ»ùÒò±»Ñ¡×÷½øÒ»²½µÄÑо¿¡£Í¬ÑùAFLP¼¼Êõ»¹±»ÓÃÓÚ¹ÇËèÒÆÖ²Ç¶ºÏÏÖÏóµÄ¼à¿Ø[25]¡£

½áÓ

AFLP¼¼ÊõÓÉÓÚ¾ßÓжà̬ÐÔÇ¿¡¢·Ö±æÂʸߡ¢Öظ´ÐԺõÈÓŵ㣬Òѹ㷺ÓÃÓÚÒÅ´«Í¼Æ×¹¹½¨¡¢ÒÅ´«¶à̬ÐÔ·ÖÎö¡¢Æ·ÖÖ¼ø¶¨µÈ£¬µ«×÷ΪһÖÖÐÂÐ˵ķÖ×Ó±ê¼Ç¼¼Êõ»¹´æÔÚ×ÅȱÏÝ£¬AFLP¼¼ÊõÊܵ½Æä¹²ÏÔÐÔÐÔÖʵÄÏÞÖÆ,²»ÄÜÏó΢ÎÀÐǺ͵Èλø¼¼ÊõÄÇÑùÇåÎúµØ½øÐÐÖÖȺÒÅ´«Ñ§·ÖÎö¡£AFLP¼¼ÊõÓë΢ÎÀÐÇ¡¢DNA²âÐòµÈ¼¼ÊõµÄ½áºÏ½«¸üºÃµÄ·¢»Ó×÷Óá£

²Î¿¼ÎÄÏ×£º

[1]  VosP,Hogers R, BleekerMetal.AFLP:a new technique for DNA finger printing .Nucleic Acids Research,1995,21: 4407¡«4414.

[2]  Zabeau M, Vos P. Selective restriction fragment amplification: a general method for DNA finger printing[P]. European Patent Office Publication 1993,0535858AI.

[3]  Zabeau M, Vos P. Selective restriction fragment amplification: a general method for DNA finger printing[P]. European Patent Office Publication number:92402629.7,1993. Publication number EP0534858.

[4]  Becker J, Vos P, Kuiper M, et al. Combined mapping of AFLP and RFLP markers in barley. Mol Gen Genet, 1995,249(1):65¡«73.

[5]  Otsen M, denBieman M, Kuiper MT, et al, Use of AFLP markers for gene mapping and QTL detection in the rat. Genomics,1996,37(3):289¡«294.

[6]  Rademarker JL, Hoste B, Louws FJ, et al. Comparison of AFLP and rep-PCR genomic finger printing with DNA homology studies: Xanthomonas as a model system. Int J Syst Evol Microbiol,2000,50(£Ð£ô2):665¡«677.

[7]  Velappan N, Sondgrass JL, Hakovirta JR, et al. Rapid identification of pathogenic bacteria by single enzyme amplified fragment length polymorphism analysis[J] . Diagnostic Microbiology and Infections Disease 2001,39:77 83.

[8]  Fukuda T, Kido A, Kajino K, et al. Cloning of differentially expressed genes in highly and low metastatic rat osteosarcomas by a modified cDNA AFLP method. Biochem Biophys Res     Commun,1999,261(1):35¡«40.

[9]  Lin JJ, Kuo J, Ma J, et ail. APCR based DNA fingerprinting technique: AFLP for molecular typing of bacteria[J]. Nncleic acids Research 1996,24(18):3649 3650.

[10]  Jones CJ. Reproducibility testing of RAPD,AFLP and SSR markers in plants by a network of European laboratories. Mol Breed,1997,3:381¡«390.

[11]  Èξü,»ÆÂ·Éú,,°¬»ªË®µÈ. 24¸öÖÐÍâÖíÖÖ(Ⱥ)µÄAFLP¶à̬ÐÔ¼°ÆäȺÌåÒÅ´«¹ØÏµ. ÒÅ´«Ñ§±¨,29(9):774¡«781,2002

[12]  Janssen P, Coopman G, Huys J, et al. Evaluation of the DNA finger printing method AFLP as a new tool in bacterial taxonomy[J]. Microbiology 1996,142:1881 1893.

[14]  VosP,Hogers R, BleekerMetal.AFLP:a new technique for DNA finger printing .Nucleic Acids Research,1995,21: 4407¡«4414.

[15]  Powell W, et al. Heredity, 1997,79:48¡«59.

[16]  Otsen M, denBieman M, Kuiper MT, et al, Use of AFLP markers for gene mapping and QTL detection in the rat. Genomics,1996,37(3):289¡«294.

[17]  International plant genome conference ¢ö January,1996. San Dioge, USA||San Dioge, USA

[18]  Tan Y D, Wan C, Zhu Y, Lu C, et al. An amplified fragment length polymorphism map of the silkworm. Genetics, 2001157(3):1277-1284.

[19] Thomas C M, Vos P, et al .Identification of amplified restriction fragment polymorphism(AFLP) markers tightly linked to the tomato cf9 gene for resistance to cladosporium fulvum .The Plant Journal , 1995,8(5) :785¡«794

[20]  Maughan P ,et al .Theor Appl Genet, 1996,93:392¡«401.

[21]  ÁºÖÇÓÂ,Ê·¾°ÈªµÈ. 10¸öƷϵСÊóµÄAFLP·ÖÎö. µÚÈý¾üÒ½´óѧѧ±¨,2003,1(25):155¡«159

 [22]  Ajmonemarsan P, Kuiper M, Valentini A et al. Animal Genetic, 1996,27:17.

[23]  Judy Huston. Canine Genetic Diseases Affecting The German Shepherd Dog

[24]  Majima S, Kajima K, Fukuda T, et al. A novel gene ¡°niban¡± up regulated in renal carcinogenesis: cloning by the cDNA amplified fragment length polymorphism approach. Jpn Cancer Res, 2000,91(9):869¡«874.

[25]  Schreiner T, Prochnow Calzia H, Maccari B, et al. Chimerism analysis after allogeneic bone marrow transplantation with nonradioactive RFLP and PCR AFLP using the same DNA. J Immunol Methods, 1996,196(1):93¡«96.
 
 
  À¸Ä¿µ¼º½
 
 
  Ïà¹Ø¶¯Îï·±Ö³
 
 
  ¹ã¸æÒ²¾«²Ê